dacarbazine has been researched along with Pheochromocytoma in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.70) | 18.7374 |
| 1990's | 11 (29.73) | 18.2507 |
| 2000's | 14 (37.84) | 29.6817 |
| 2010's | 10 (27.03) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Del Rivero, J; Ilanchezhian, M; Jha, A; Pacak, K | 1 |
| Ben-Maimon, S; Cengel, K; Cohen, DL; Fishbein, L; Fraker, DL; Keefe, S; Loaiza-Bonilla, A; Nathanson, KL; Pryma, DA | 1 |
| Jessop, A; Jimenez, C; Jimenez, P; Tatsui, C; Thosani, S | 1 |
| Bertorelle, R; Ferrara, AM; Iacobone, M; Lombardi, G; Meringolo, D; Nardin, M; Opocher, G; Pambuku, A; Schiavi, F; Zagonel, V; Zovato, S | 1 |
| Al Ghuzlan, A; Amar, L; Baudin, E; Bertherat, J; Borget, I; Caramella, C; Chougnet, C; Déandreis, D; Deschamps, F; Dumont, F; Favier, J; Gimenez-Roqueplo, AP; Hadoux, J; Leboulleux, S; Letouzé, E; Libé, R; Loriot, C; Schlumberger, M; Scoazec, JY; Young, J | 1 |
| Alblas, G; Corssmit, EP; Dekkers, OM; Niemeijer, ND; van Hulsteijn, LT | 1 |
| Deutschbein, T; Fassnacht, M; Mann, K; Petersenn, S; Reincke, M; Weismann, D | 1 |
| Asai, S; Katabami, T; Naruse, M; Tanaka, Y; Tsuiki, M | 1 |
| Abraham, J; Averbuch, S; Fojo, T; Huang, H; Hung, E; Merino, M; Pacak, K; Steinberg, SM | 1 |
| Kimura, H; Kodama, H; Nomura, K; Obara, T; Okamoto, T; Shimizu, S; Takano, K | 1 |
| Azuma, H; Ibuki, N; Inamoto, T; Katsuoka, Y; Komura, K; Koyama, K; Segawa, N; Tanimoto, K; Tuji, M | 1 |
| Mugiya, S; Nagata, M; Nishijima, N; Ozono, S; Takayama, T; Ushiyama, T | 1 |
| Bernardo, M; Chiang, J; Lonser, R; Lu, J; Martiniova, L; Pacak, K; Zhuang, Z | 1 |
| Ichihara, A; Naruse, M; Nomura, K; Tanabe, A; Tsuiki, M; Tsumagari, A | 1 |
| Keiser, HR; O'Connor, DT; Rao, F | 1 |
| Miyoshi, Y; Naoi, Y; Noguchi, S; Ooka, M; Taguchi, T; Tamaki, Y; Tanji, Y; Tsukamoto, F | 1 |
| Ehrlich, LD; Fojo, T; Louie, A; Pacak, K; Padmanabhan, H; Quazedo, M; Walther, M | 1 |
| Aiba, K; Fukui, I; Hatake, K; Horikoshi, N; Ishikawa, Y; Ito, Y; Kage, K; Koizumi, M; Nakane, M; Ogata, E; Sekine, I; Takahashi, S | 1 |
| Kanno, N; Kawano, K; Miyoshi, S; Mukai, M; Nakagawa, M; Nishimura, K; Uemura, M; Yoshida, K | 2 |
| Clark, JW; Enzinger, PC; Fuchs, CS; Kulke, MH; Michelini, A; Muzikansky, A; Ryan, DP; Stuart, K; Vincitore, M | 1 |
| Naruse, M; Takano, K; Tanabe, A; Tsuiki, M | 1 |
| Dralle, H; Eisenhofer, G; Lehnert, H; Pacak, K; Scholz, T | 1 |
| Mizuno, O | 1 |
| Inoue, J; Iwaoka, T; Naomi, S; Oishi, S; Sasaki, M; Sato, T; Tokunaga, H; Umeda, T; Yamauchi, J | 1 |
| Hosoi, S; Itoh, H; Kojima, M; Minamikawa, T; Ukimura, O; Watanabe, H | 1 |
| Averbuch, S; Bruckner, H; Dicpinigaitis, P; Manger, W; Wu, LT | 1 |
| Abe, K; Akama, H; Honma, H; Kusakari, T; Miura, W; Miura, Y; Noshiro, T; Shibukawa, S; Shimizu, K; Watanabe, T | 1 |
| Baba, K; Doi, Y; Hayano, M; Minami, K; Minami, T; Oshibuchi, E; Seto, S; Suzuki, S; Tetsuo, H; Yano, S | 1 |
| Kopf, D; Lehnert, H; Mundschenk, J | 1 |
| Okuda, Y; Tada, K; Yamashita, K | 1 |
| Shapiro, B; Shulkin, BL; Sisson, JC; Spaulding, S; Urba, S; Zempel, S | 1 |
| Imao, S; Ishiwata, S; Mikata, N; Nagano, T; Suzuki, M | 1 |
| Fukui, I; Hasegawa, Y; Ishikawa, Y; Isii, N; Maezawa, T; Tsukamoto, T; Yonese, J | 1 |
| Kanai, T; Katagiri, A; Katayama, Y; Kawakami, Y; Kimura, M; Komeyama, T; Odano, I; Sato, S; Takeda, M; Tsutsui, T | 1 |
| Engelhardt, D; Jacob, K; Mann, K; Markl, A; Saller, B; Zwiebel, FM | 1 |
| Averbuch, SD; Gelmann, EP; Goldstein, DS; Keiser, HR; Steakley, CS; Stull, R; Young, RC | 1 |
9 review(s) available for dacarbazine and Pheochromocytoma
| Article | Year |
|---|---|
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Cytoreduction Surgical Procedures; Dacarbazine; Everolimus; Humans; Liver Neoplasms; Lung Neoplasms; Octreotide; Paraganglioma; Pheochromocytoma; Poly(ADP-ribose) Polymerase Inhibitors; Radiopharmaceuticals; Surgical Procedures, Operative; Vincristine | 2020 |
Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress.
Topics: Adrenal Gland Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Humans; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Vincristine | 2017 |
Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Catecholamines; Cyclophosphamide; Dacarbazine; Humans; Paraganglioma; Pheochromocytoma; Tumor Burden; Vincristine | 2014 |
[A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Drug Administration Schedule; Humans; Male; Middle Aged; Pheochromocytoma; Vincristine | 2003 |
[Malignant pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Catecholamines; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Diagnosis, Differential; Diagnostic Imaging; Germ-Line Mutation; Humans; Iodine Radioisotopes; Pheochromocytoma; Prognosis; Radiopharmaceuticals; Succinate Dehydrogenase; Vincristine | 2006 |
Clinical review: Current treatment of malignant pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Humans; Iodine Radioisotopes; Pheochromocytoma; Vincristine | 2007 |
[A case of malignant pheochromocytoma treated with a combination of cyclophosphamide, vincristine, and dacarbazine (CVD). A review of the Japanese literature of malignant pheochromocytoma treated with a combination of CVD].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Female; Humans; Middle Aged; Pheochromocytoma; Treatment Failure; Vincristine | 1994 |
[Case of malignant pheochromocytoma with successful control of systemic metastasis with CVD chemotherapy].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pheochromocytoma; Vincristine | 1996 |
[Low dose CVD chemotherapy as a tumor dormancy therapy for extra-adrenal malignant pheochromocytoma: a case report].
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Drug Administration Schedule; Humans; Male; Pheochromocytoma; Vincristine | 2001 |
5 trial(s) available for dacarbazine and Pheochromocytoma
| Article | Year |
|---|---|
Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dacarbazine; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pheochromocytoma; Treatment Outcome; Vincristine | 2008 |
Malignant and benign pheochromocytoma: chromaffin granule transmitters and the response to medical and surgical treatment.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Chromogranin A; Chromogranins; Cyclophosphamide; Dacarbazine; Epinephrine; Humans; Norepinephrine; Pheochromocytoma; Vincristine | 2002 |
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Carcinoma, Islet Cell; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pheochromocytoma; Survival Analysis; Temozolomide; Thalidomide; Treatment Outcome | 2006 |
[Therapy of malignant pheochromocytoma. Invitation to participate in a randomized multicenter study].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Dacarbazine; Drug Therapy, Combination; Humans; Indium Radioisotopes; Injections, Subcutaneous; Interferon-alpha; Iodine Radioisotopes; Octreotide; Pheochromocytoma; Placebos; Radionuclide Imaging; Radiopharmaceuticals; Time Factors; Vincristine | 1998 |
Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Female; Humans; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Vincristine | 1999 |
23 other study(ies) available for dacarbazine and Pheochromocytoma
| Article | Year |
|---|---|
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Female; Humans; Male; Middle Aged; Mutation; Pheochromocytoma; Succinate Dehydrogenase; Vincristine; Young Adult | 2017 |
Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Alkylating; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Dacarbazine; Female; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Temozolomide | 2018 |
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Brain Neoplasms; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mutation; Neoplasm Metastasis; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Polymerase Chain Reaction; Prognosis; Promoter Regions, Genetic; Retrospective Studies; Succinate Dehydrogenase; Survival Rate; Temozolomide; Tumor Suppressor Proteins | 2014 |
Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Clinical Protocols; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pheochromocytoma; Retrospective Studies; Treatment Outcome; Vincristine | 2015 |
Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paraganglioma; Pheochromocytoma; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2017 |
Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Pheochromocytoma; Survival Rate; Vincristine | 2009 |
[A pheochromocytoma of urinary bladder treated with neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Female; Humans; Neoadjuvant Therapy; Pheochromocytoma; Urinary Bladder Neoplasms; Vincristine | 2009 |
[Clinical course of patient with malignant pheochromocytoma who was treated with CVD chemotherapy and alpha-methyl-p-tyrosine].
Topics: Adult; alpha-Methyltyrosine; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Diagnostic Imaging; Disseminated Intravascular Coagulation; Enzyme Inhibitors; Fatal Outcome; Female; Humans; Pheochromocytoma; Vincristine | 2010 |
Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy.
Topics: Adrenal Gland Neoplasms; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dacarbazine; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Humans; Mice; Neoplasm Metastasis; Pheochromocytoma; Phosphorylation; Protein Kinase Inhibitors; Protein Phosphatase 2; Serine; Temozolomide; Threonine | 2011 |
Combination chemotherapy with cyclophosphamide, vincristine, and dacarbazine in patients with malignant pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Vincristine | 2013 |
Unusual locations of involvement by malignancies: Case 2. Metastatic pheochromocytoma to the colon.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Colonoscopy; Cyclophosphamide; Dacarbazine; Diagnosis, Differential; Humans; Male; Pheochromocytoma; Urinary Bladder Neoplasms; Vincristine | 2003 |
Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Humans; Male; Middle Aged; Pheochromocytoma; Vincristine | 2003 |
[Malignant pheochromocytoma responsive to multimodal therapy: a case report].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Drug Administration Schedule; Humans; Male; Middle Aged; Pheochromocytoma; Radiotherapy, Adjuvant; Vincristine | 2003 |
[A case of extra-adrenal pheochromocytoma presenting with lung metastasis].
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Nephrectomy; Pheochromocytoma; Pneumonectomy; Treatment Outcome; Vincristine | 2004 |
A case of Sipple's syndrome with malignant pheochromocytoma treated with 131I-metaiodobenzyl guanidine and a combined chemotherapy with cyclophosphamide, vincristine and dacarbazine.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Multiple Endocrine Neoplasia Type 2a; Pheochromocytoma; Vincristine | 1994 |
[A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and CVD regimen].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Pheochromocytoma; Vincristine | 1994 |
Hypertensive crises induced by treatment of malignant pheochromocytoma with a combination of cyclophosphamide, vincristine, and dacarbazine.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Female; Humans; Hypertension; Male; Middle Aged; Pheochromocytoma; Vincristine | 1994 |
Two cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine and dacarbazine in a combined chemotherapy.
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Follow-Up Studies; Humans; Lung; Male; Norepinephrine; Pheochromocytoma; Radiography, Abdominal; Radiotherapy, Adjuvant; Time Factors; Tomography, X-Ray Computed; Vincristine | 1996 |
Three cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine, and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia.
Topics: Adrenal Gland Neoplasms; Adult; alpha-Methyltyrosine; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Catecholamines; Cyclophosphamide; Dacarbazine; Female; Humans; Hyperlipidemias; Liver Neoplasms; Lung Neoplasms; Male; Pheochromocytoma; Spinal Neoplasms; Vincristine | 1998 |
[Malignant pheochromocytoma with remarkable response to CVD chemotherapy--a case report].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Drug Administration Schedule; Humans; Male; Middle Aged; Pheochromocytoma; Vincristine | 2000 |
[Treatment of malignant pheochromocytoma by combination of CVD regimen and transarterial embolization].
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Embolization, Therapeutic; Female; Humans; Male; Middle Aged; Pheochromocytoma; Vincristine | 1991 |
[Recurrent hypertensive crises and dyspnea following unilateral adrenalectomy in pheochromocytoma in a 44-year-old patient. Successful combination chemotherapy of malignant pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Dyspnea; Female; Follow-Up Studies; Humans; Hypertension; Neoplasm Metastasis; Phenoxybenzamine; Pheochromocytoma; Tomography, X-Ray Computed; Vincristine | 1990 |
Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Catecholamines; Cyclophosphamide; Dacarbazine; Female; Humans; Male; Metanephrine; Middle Aged; Pheochromocytoma; Vanilmandelic Acid; Vincristine | 1988 |